Mutaflor is a probiotic comprised of a viable non-pathogenic bacteria strain named Escherichia coli Nissle 1917. Mutaflor has been on the market for almost a century and has been clinically studied for use in a variety of diseases and disorders of the gastrointestinal tract. A number of European studies on E. coli Nissle 1917 have shown positive results when used in conditions such as ulcerative colitis, Crohn’s Disease, chronic constipation, prolonged diarrhea, irritable bowel syndrome and pouchitis. In Canada, Mutaflor is indicated to normalize stool frequency and consistency in diarrhea and constipation and to reduce abdominal pain and cramping. Please note that Medical Futures Inc. is the official, authorized distributor for Mutaflor in Canada and Mutaflor in the USA.